$OXGN-OXiGENE Announces Agreement With FDA on Special Protocol Assessment for a Phase 3 Trial of ZYBRESTAT(R) in Anaplastic Thyroid Cancer

Sep18
2012 Leave a Comment Written by THESTOCK411.COM

UP 30+%

2013-05-17 17:15

Fed's Bullard: Need Faster Inflation Before Tapering Stimulus - Wall Street Journal
Nikkei's U-turn may not be the big trigger for a Wall Street pullback - MarketWatch
China May Factory Output Contracts in Test for Premier: Economy - Bloomberg
IMF head Lagarde in court in fraud probe - Boston.com
Solar plane sets distance record on US tour - AFP

TheStock411.com
Your Growth-Focused Investment Blog: Reliable and Educated Stock Tips